D. E. Shaw & Co., Inc. Omega Therapeutics, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding OMGA
# of Institutions
58Shares Held
43.4MCall Options Held
25.8KPut Options Held
7K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$23.1 Million6.05% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$2.77 Million2.28% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$1.47 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY1.32MShares$1.05 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$880,6370.0% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $37.8M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...